Etoposide (Vepesid)

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

General information

Class/mechanism: Topoisomerase II inhibitor. Causes DNA strand breaks by interacting with DNA-topoisomerase II or by forming free radicals. Causes arrest at the G2 portion of the cell cycle, with dose dependent effects: at high concentrations, cells entering mitosis undergo lysis; at low concentrations, cells are inhibited from entering prophase.[1][2]
Route: IV, PO
Extravasation: irritant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

Also known as

Synonyms
Abic Etoposide Aside Beposid Bioposide BO RUI Bristol VP-16 Celltop Citodox
Epocin Eposid Eposide Eposido Eposin Epsidox ETO Etocris
Etomedac Etonolver Etopofos Etopophos Etopos Etoposid Etoposide Abic Etoposid Ebewe
Etoposide Bigmar Etoposide BVI Etoposide Dakota Etoposide DBL Etoposide DUP Etoposide Ebewe Etoposide Eurocept Etoposide Merck
Etoposide Pfizer etoposide phosphate Etoposide Teva Etoposid Mayne Etoposido Etoposido Delta Farma Etoposido Ferrer Etoposido GI Kendr
Etoposido Servycal Etoposido Varifarm Etoposid Proreo Etoposid Teva Etopoxan Etopul Etosid Etosin
Eunades CS Euvaxon Exitop Fytop Fytosid HAI WEI LIN Labimion Lastet
Lastet S Neoplaxol Nexvep Onkoposid Optasid P&U Etoposide Percas Posid
Posidon Posyd Riboposid Sintopozid Toposar Toposide Toposin Topresid
Tosuben Vepefos Vepeside Vepesid K Vepesid S Vepesid VP-16 Vepsid Vepside
VP-16 VP-TEC VP 16213

References